RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TAVELLI A
Collezione ASL Città di Torino

Items : 6

Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2024 Oct 1;79(10):2662-2667. doi: 10.1093/jac/dkae273.

2024
ASL Città di Torino

Cingolani A; Tavelli A; De Benedittis S; Mastrorosa I; Muccini C; Bini T; Carraro A; Compagno M; Mazzitelli M; Guastavigna M; Cernuschi M; Torti C; Antinori A; d'Arminio Monforte A;

Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2024 May;142:106995. doi: 10.1016/j.ijid.2024.106995. Epub 2024 Mar 6.

2024
ASL Città di Torino

Mondi A; Cozzi-Lepri A; Tavelli A; Cingolani A; Giacomelli A; Orofino G; De Girolamo G; Pinnetti C; Gori A; Saracino A; Bandera A; Marchetti G; Girardi E; Mussini C; d'Arminio Monforte A; Antinori A;

Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2024 Jun 3;79(6):1279-1288. doi: 10.1093/jac/dkae081.

2024
ASL Città di Torino

d'Arminio Monforte A; Tavelli A; Di Biagio A; Sarmati L; Marchetti GC; Bai F; Cingolani A; Quiros Roldan E; Mussini C; Lichtner M; Vergori A; Piconi S; Orofino G; Fusco FM; Bandera A; Nozza S; Castagna A; Antinori A;

Safety and efficacy of daclatasvir at doses other than 60?mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2020 Apr;52(4):447-451. doi: 10.1016/j.dld.2019.12.007. Epub 2020 Jan 17.

2020
ASL Città di Torino

Rossotti R; Tavelli A; Bonora S; Cingolani A; Lo Caputo S; Saracino A; Soria A; Marinaro L; Uberti-Foppa C; Mussini C; Puoti M; d'Arminio Monforte A;

Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort. in Journal of the International AIDS Society / J Int AIDS Soc. 2019 Jan;22(1):e25227. doi: 10.1002/jia2.25227.

2019
ASL Città di Torino

Mondi A; Cozzi-Lepri A; Tavelli A; Rusconi S; Vichi F; Ceccherini-Silberstein F; Calcagno A; De Luca A; Maggiolo F; Marchetti G; Antinori A; d'Arminio Monforte A;

First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison. in HIV medicine / HIV Med. 2018 May 30. doi: 10.1111/hiv.12628.

2018
ASL Città di Torino

Taramasso L; Di Biagio A; Maggiolo F; Tavelli A; Lo Caputo S; Bonora S; Zaccarelli M; Caramello P; Costantini A; Viscoli C; d'Arminio Monforte A; Cozzi-Lepri A;